Features of Cytomegalovirus DNAemia Blips in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Implications for Optimization of Preemptive Antiviral Therapy Strategies

Pérez-Romero, 2015, An update on the management and prevention of cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation, Future Virol, 10, 113, 10.2217/fvl.14.102 Chemaly, 2014, Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation, N Engl J Med, 370, 1781, 10.1056/NEJMoa1309533 Marty, 2017, Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation, N Engl J Med, 377, 2433, 10.1056/NEJMoa1706640 Boeckh, 2009, How we treat cytomegalovirus in hematopoietic cell transplant recipients, Blood, 113, 5711, 10.1182/blood-2008-10-143560 Ljungman, 2019, Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7), Lancet Infect Dis, 19, e260, 10.1016/S1473-3099(19)30107-0 Tan, 2015, Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients, J Clin Virol, 69, 179, 10.1016/j.jcv.2015.06.006 Green, 2016, CMV viral load and mortality after hematopoietic cell transplantation: a cohort study in the era of preemptive therapy, Lancet Haematol, 3, e119, 10.1016/S2352-3026(15)00289-6 Solano, 2013, Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center, Bone Marrow Transplant, 48, 1010, 10.1038/bmt.2012.286 Solano, 2016, Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood, Bone Marrow Transplant, 51, 718, 10.1038/bmt.2015.303 Solano C, Giménez E, Piñana JL, et al. Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients [e-pub ahead of print]. Transpl Infect Dis. 2017;19. doi: 10.1111/tid.12717. Epub 2017 Jun 20. PMID: 28471073 Giménez, 2019, Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): a systematic review, meta-analysis, and meta-regression analysis, Am J Transplant, 19, 2479, 10.1111/ajt.15515 Hill, 2018, Kinetics of double-stranded DNA viremia after allogeneic hematopoietic cell transplantation, Clin Infect Dis, 66, 368, 10.1093/cid/cix804 Lodding, 2018, Impact of CMV PCR blips in recipients of solid organ and hematopoietic stem cell transplantation, Transplant Direct, 4, e355, 10.1097/TXD.0000000000000787 Clari, 2013, Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia, Diagn Microbiol Infect Dis, 75, 207, 10.1016/j.diagmicrobio.2012.10.010 Tremblay, 2015, Cytomegalovirus quantification in plasma with Abbott RealTime CMV and Roche Cobas Amplicor CMV assays, J Virol Methods, 225, 1, 10.1016/j.jviromet.2015.08.010 Ljungman, 2017, Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials, Clin Infect Dis, 64, 87, 10.1093/cid/ciw668 Glucksberg, 1974, Clinical manifestations of graft-versus- host disease in human recipients of marrow from HL-A-matched sibling donors, Transplantation, 18, 295, 10.1097/00007890-197410000-00001 Havlir, 2001, Prevalence and predictive value of intermittent viremia with combination HIV therapy, JAMA, 286, 171, 10.1001/jama.286.2.171 Poveda, 2018, Hot news: impact of low-level viremia on treatment outcomes during ART—is it time to revise the definition of virological failure?, AIDS Rev, 20, 71 Talaya, 2019, Spontaneously-resolving episodes of cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: virological features and clinical outcomes, J Med Virol, 91, 1128, 10.1002/jmv.25426 Meesing, 2020, Differences in duration and degree of cytomegalovirus DNAemia observed with two standardized quantitative nucleic acid tests and implications for clinical care, J Infect Dis, 221, 251, 10.1093/infdis/jiz452 Giménez, 2018, Cytomegalovirus DNAemia burden and mortality following allogeneic hematopoietic stem cell transplantation: an area under a curve-based investigational approach, Clin Infect Dis, 67, 805, 10.1093/cid/ciy138